Murphy, Middleton, Hinkle & Parker »

Takeda Pharmaceutical shares owned by Murphy, Middleton, Hinkle & Parker

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Murphy, Middleton, Hinkle & Parker from 13F filings

Historical chart of Murphy, Middleton, Hinkle & Parker investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Murphy, Middleton, Hinkle & Parker consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Murphy, Middleton, Hinkle & Parker

Quarter filed Position value Share count Share price at filing
2025-12-31 $467k 714 653.57

More positions owned by Murphy, Middleton, Hinkle & Parker

PPG Industries (PPG)
Netflix (NFLX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Invesco Exchange Traded Fd T Water Res Etf (PHO)
Carnival Corp Unit 99/99/9999 (CCL)
Baxter International (BAX)
Bank of New York Mellon Corporation (BK)
Home Depot (HD)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Prudential Financial (PRU)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Procter & Gamble Company (PG)
Oshkosh Corporation (OSK)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Ishares Silver Tr Ishares (SLV)

View all positions for Murphy, Middleton, Hinkle & Parker

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Goldman Sachs Group
FMR
UBS Group
Brandes Investment Partners
Renaissance Technologies
BlackRock
Toronto-Dominion Bank
Arrowstreet Capital, Limited Partnership
Millennium Management
First Trust Advisors
Northern Trust
Qube Research & Technologies
Citadel Advisors
Managed Asset Portfolios

View all funds holding Takeda Pharmaceutical